CryoLife (CRY) Reports In-Line Q1 EPS

CryoLife (NYSE: CRY) reported Q1 EPS of $0.02, in-line with the analyst estimate of $0.02. Revenue for the quarter came in at $61.9 million versus the consensus estimate of $60.29 million.

GUIDANCE:

CryoLife sees Q2 2018 revenue of $63-65 million, versus the consensus of $63.9 million.

CryoLife sees FY2018 EPS of $0.29-$0.32, versus the consensus of $0.31. CryoLife sees FY2018 revenue of $250-256 million, versus the consensus of $252.9 million.

For earnings history and earnings-related data on CryoLife (CRY) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c